Skip to content
EmergingResearch compoundReference only

Unifiram

Experimental nootropic related to Sunifiram: studied only in animals, with no human data.

NootropicNootropicampakineglutamateGlutamateAcetylcholine

Pharmacology

ClassNootropic · ampakine · glutamate
Primary targetAMPA receptors (ampakine-like enhancement)
Targets3 receptor targets
EvidenceReference only
Affected systemsGlutamateAcetylcholine

Contents

Related comparisons

Sunifiram vs Unifiram

DETAILED OVERVIEW

What is Unifiram?

Unifiram (DM-232) is an experimental compound designed in the lab as a relative of Sunifiram, another nootropic (a substance meant to support brain function). It is not approved as a medicine anywhere: in the United Kingdom the Psychoactive Substances Act bans it, and elsewhere it is sold as a research chemical.

In animal studies on rats it improved memory, and it probably acts through the brain's glutamate messenger system, but its exact mechanism is not clear. It has hardly been studied in humans, so there are no reliable data on its real effects or safety. User reports mention anxiety, tension, restlessness and sleep problems. In theory it could raise the risk of seizures in epilepsy. Its safety in pregnancy and breastfeeding is not established because there are no human data, so it should be avoided.

Mechanism

AMPA-PAM (Sunifiram-like)

Half-life

No human data

Legal status

Investigational, not approved

Receptor profile

  • AMPA receptorsStrong
  • Hippocampal excitatory transmissionStrong
  • Cholinergic systemModerate

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • No human safety data, only preclinical (rodent) and anecdotal reports
  • Anxiety, tension and restlessness (highly individual response)
  • Stimulating, energizing effect that can tip into overstimulation at higher doses
  • Possible sleep disruption if taken late in the day (stimulant-like profile)
  • Headache or agitation theoretically arising from glutamatergic (AMPA/NMDA) modulation
  • Unknown long-term safety, unknown tolerance and risk profile

Contraindications · 5

  • Pregnancy and breastfeeding: strictly avoid due to lack of human data
  • Caution with anxiety disorders or panic tendency (the stimulating effect may worsen them)
  • Epilepsy or seizure-threshold disorders: glutamatergic excitation may theoretically raise seizure risk
  • Combined with other stimulants or caffeine, increased agitation and anxiety are possible
  • Experimental, nowhere-approved substance; no established safe dosing or drug-interaction profile

Related Nootropics

Same therapeutic category

FAQ

FAQ

Unifiram is an experimental, lab-designed compound developed as a relative of the nootropic Sunifiram, and it showed memory-enhancing effects at very low doses in animal studies. Importantly, there is essentially no human research on it, so this is a purely research-stage substance with very little data on its real-world effects or safety in people.

Telegram

Have a question about Unifiram?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC13H15FN2O3S
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.